{ "schemaVersion": "deck-intelligence.v1", "id": "019dd923-5fec-763b-95ce-df36eb136cb7", "slug": "v2M0U9ih51yxmXlSsD1M", "title": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad", "subtitle": "Beckley Psytech", "author": "Beckley Psytech", "pageCount": 22, "kind": "pitchdeck", "orientation": "landscape", "aspectRatio": 1.777, "document": { "id": "019dd923-5fec-763b-95ce-df36eb136cb7", "slug": "v2M0U9ih51yxmXlSsD1M", "title": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad", "rawTitle": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad", "authorId": "Pitchdecks", "authorName": "Beckley Psytech", "authorDisplay": "Beckley Psytech", "kind": { "slug": "pitchdeck", "label": "Pitch deck" }, "sourceType": { "slug": "strategy_consulting", "label": "Strategy consulting" }, "fileName": "Psychedelics-v2M0U9ih.pdf", "sourceUrl": "https://www.businessinsider.com/psychedelics-startup-beckley-psytech-pitch-deck-186-million-2020-12", "sourceDate": "2020-12-18 00:00:00", "presentationDate": null, "ingestedAt": "2026-04-27 09:24:27.645+00", "status": "ready", "pageCount": 22, "orientation": "landscape", "aspectRatio": 1.777, "targetCompany": null, "targetTicker": null, "metadata": { "local_root": "/tmp/legacy-images/v2M0U9ih51yxmXlSsD1M", "origin_corpus": "consulting" } }, "coverage": { "pageCount": 22, "pagesIndexed": 22, "pagesWithImages": 22, "pagesWithMetadata": 22, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 84, "chartCount": 0, "metricSlides": 0, "toolMatches": 9, "documentToolMatches": 0, "frameworkMatches": 7, "arcMatches": 1, "beatMatches": 3, "loopMatches": 1, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": true, "pitchdeckProfileAvailable": true }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "evidence": "The deck follows a similar structure to the Sequoia Pitch, with sections on problem, solution, market size, product, and team", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 21:39:52.061374+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 8, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 8, "name": "Problem", "beatId": "1992a52c-562b-47d0-93a8-64dd2cb68b0a", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Problem", "slug": "sequoia-pitch-problem", "status": "active", "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311", "version": 1, "description": null }, "evidence": "The problem statement is clearly outlined on page 8", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 13, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 13, "name": "Solution", "beatId": "5446c3f5-6fb8-46c6-8fbf-e9043d2e5999", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The solution is described on page 13", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 15, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 14, "name": "Team", "beatId": "ac05d62d-4136-4eff-9e6c-66111ab0e59f", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Team", "slug": "sequoia-pitch-team", "status": "active", "canonId": "019dd9b8-23c9-746f-aaf9-2f5d83892cf3", "version": 1, "description": null }, "evidence": "The leadership team and scientific advisors are introduced on pages 14-15", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 11, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "73496664-182b-4790-bfd4-11bd301d81a0", "evidence": "The deck highlights macroeconomic drivers and the current opportunity on pages 9-11", "position": 0, "objective": "Why now is the right time for psychedelic drug development", "confidence": 0.7, "extraction": { "at": "2026-07-16 21:39:52.216559+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "5ebb2e79-3ce8-4a39-b6e3-ef9b190f2fb4", "evidence": "Beckley Psytech: A leading Psychedelic Drug Development Platform positioned for significant growth", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 22:31:52.387704+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "bf75e02d-622a-4d14-a94e-87710c5f081d", "evidence": "Leadership Team: World-leading psychedelic researchers, drug development experts and business shapers with proven success", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:31:40.827081+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Authority Bias", "slug": "authority-bias", "status": "active", "bestFor": null, "canonId": "019dd956-c38d-70b9-a284-b2b479763356", "version": 1, "bodyDocId": null, "description": "Expert opinions are weighted more heavily - cite credible sources", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Architect", "Storyteller" ], "matchId": "558008c9-a2e1-45f0-8a76-f704e0204def", "evidence": "World-leading psychedelic researchers, drug development experts and business shapers with proven success", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:40.87067+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "62584930-54a6-48a4-9057-21f6b7ee75ea", "evidence": "Providing world-leading expertise across the development pathway and scientific objectivity to our decision making", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:31:40.956008+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Credibility Transfer", "slug": "credibility-transfer", "status": "active", "bestFor": null, "canonId": "019dd956-bd34-759a-8e3b-2f14b571a2a1", "version": 1, "bodyDocId": null, "description": "Borrowing authority from trusted sources or vivid details", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "3acf9e5e-44f3-4574-b20d-9bb7214b9bf9", "evidence": "Institutional logos: Oxford, King's College, Johns Hopkins, Imperial College, Manchester University, Sinto Pharma", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:40.999247+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Network Effects Flywheel", "slug": "network-effects-flywheel", "status": "active", "bestFor": null, "canonId": "79fa8d3e-ef02-4ee8-ad12-f8e00a25cca1", "version": 1, "bodyDocId": null, "description": null, "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "c114878c-8de2-49a5-94cd-c8dc21b0049a", "evidence": "Global Research Network: Close strategic partnership with the Beckley Foundation opens up opportunities from a network of ongoing and future research collaborations around the world", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:41.087721+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 16, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Market Segmentation Pyramid", "slug": "market-segmentation-pyramid", "status": "active", "bestFor": null, "canonId": "1c9f3543-c96f-4a5b-b4a4-9b2a412c0aaf", "version": 1, "bodyDocId": null, "description": null, "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "0ed014b1-4ec1-429d-89a4-675f88fc79d4", "evidence": "2nd Generation (5-MeO-DMT): Early Mover in 5-MeO-DMT. Strong potential for innovation, IP, and market exclusivity protection", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:41.219553+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 18, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Call to action", "slug": "call-to-action", "status": "active", "bestFor": null, "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c", "version": 1, "bodyDocId": null, "description": "Explicit prescription of what the audience should do next.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "8a7acdae-5cc8-4976-9eb6-5f9129d86c1b", "evidence": "Right Projects, Right Team, Right Time.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 22:31:41.394345+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 21, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Storytelling: the closing ask", "slug": "closing-ask", "status": "active", "bestFor": null, "canonId": "019df269-24e0-70ab-8dd9-983832c1c665", "version": 1, "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d", "description": "The single most important slide in the deck — after the cover. The final", "familyLabel": "narrative-block", "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "agent": "storyteller", "layer": "slide", "agents": [ "storyteller" ], "matchId": "c5ec1d25-7dc2-4396-aa26-99e8f0ceccc0", "evidence": "Thank you for your interest in becoming a Beckley Psytech investor.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 22:31:41.480918+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 22, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "e98cdbb0-eb38-4d42-b72f-7afd7f8da9d0", "evidence": "Leveraging academic research history to validate commercial startup potential.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "credibility-transfer" }, { "matchId": "876d825a-e40d-4efb-81b2-68c87b331324", "evidence": "Citing FDA-approved drugs as proof of market viability", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "authority-citation" }, { "matchId": "f2177757-55fc-47ff-8105-62a6b4a560e9", "evidence": "Chronological sequence of clinical research events.", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 16:20:47.183+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 10, "frameworkName": "timeline" }, { "matchId": "5478cb64-13e8-4a18-9989-a09fd0850b9a", "evidence": "Citing reputable news sources to validate market timing.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:46.945+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "authority-bias" }, { "matchId": "d7bc8ea7-3e20-4002-ad0a-1570c200a276", "evidence": "The slide categorizes development programs into 1st, 2nd, and 3rd generations, representing increasing levels of innovation and complexity.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 16:20:47.409+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 13, "frameworkName": "maturity-model" }, { "matchId": "c409dda2-d11f-4131-9f5a-1357de387174", "evidence": "The slide organizes programs into generations (1st, 2nd, 3rd) representing a progression of development.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 18, "frameworkName": "maturity-model" }, { "matchId": "61835825-275c-4c41-a5a1-77387764b098", "evidence": "Four overlapping circles illustrating the intersection of organizational pillars.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:48.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 20, "frameworkName": "venn-diagram" } ], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": null, "pitchdeck": { "metadata": { "author": "Yeji Jesse Lee", "fireId": "v2M0U9ih51yxmXlSsD1M", "sector": "biotech", "deckKind": "fundraise", "roundRaw": null, "amountRaw": "$18.6 million", "amountUsd": "18600000", "scrapedAt": "2026-04-27 09:24:27.645+00", "sectorRaw": "Therapeutics", "sourceUrl": "https://www.businessinsider.com/psychedelics-startup-beckley-psytech-pitch-deck-186-million-2020-12", "deckKindAt": "2026-04-28 07:19:06+00", "highlights": "UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round;; backed by investment firms Noetic Psychedelic Fund and Bail Capital. Beckley Psytech's upcoming clinical trials will be focused on researching the synthetic compound 5-MeO-DMT;; a psychedelic agent found naturally in the Sonoran Desert toad. The company says it's preparing to test other compounds as well. Subscribe to Insider Cannabis;; our weekly cannabis industry newsletter;; for more stories like this.", "slideCount": 22, "companyName": "Psychedelics", "description": "UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round;; backed by investment firms Noetic Psychedelic Fund and Bail Capital. Beckley Psytech's upcoming clinical trials will be focused on researching the synthetic compound 5-MeO-DMT;; a psychedelic agent found naturally in the Sonoran Desert toad. The company says it's preparing to test other compounds as well. Subscribe to Insider Cannabis;; our weekly cannabis industry newsletter;; for more stories like this. Cosmo Feilding Mellen was involved in the world of psychedelics long before the compounds started to become mainstream. Feilding Mellen is the cofounder and CEO of UK-based psychedelics company Beckley Psytech;; but his family — and his mother Amanda Feilding;; in particular — has been involved in the scientific studies around psychedelics since 1998. That's the year Feilding started the Beckley Foundation;; a non-profit focused on drug policy reform and scientific research into psychoactive substances. Feilding;; dubbed the Countess of Cannabis;; has been a long-time advocate for psychedelics-based therapies and is a leading advocate for reform for medical cannabis in Europe. She is currently chair of Beckley Psytech's Scientific Advisory Board. Before starting Beckley Psytech;; Feilding Mellen was deeply involved in the Beckley Foundation;; which has partnered in joint research collaborations with institutions like Imperial College London and Johns Hopkins in clinical trials of psychedelic compounds over the past 20 years. He's directed documentaries on drug policy and the history of psychedelics and worked as the managing director of the UK for Canopy Growth;; a Canadian cannabis giant. During that time;; Canopy acquired Beckley Canopy Therapeutics;; a company founded in partnership with Canopy Growth and the Beckley Foundation to develop cannabis-based medications. Beckley Psytech was formed in 2019 when the non-profit foundation began to look for business opportunities that would be able to increase the scale and ambition of the work the foundation was involved in. The foundation exists separately from the for-profit company. The for-profit venture just closed an $18.6 million funding round;; backed by investment firms Noetic Psychedelic Fund and Bail Capital. Canadian businessman Greg Bailey;; entrepreneur Jim Mellon;; and Innocent Drinks cofounder Richard Reed also invested in this round;; as well as a previous $3.8 million fund which closed in May 2020. Beckley Psytech plans to soon begin clinical trials of 5-MeO-DMT;; a psychedelic agent found naturally in the Sonoran Desert toad. Feilding Mellen said that the company is looking into other treatments as well. Cosmo Feilding Mellen;; director and CEO of Beckley Psytech Beckley Psytech \"We're setting up Beckley Psytech to be a platform where multiple drug development programs are running in parallel with different compounds;; targeting different disease areas;;\" he said in an interview. Beckley Psytech plans to look into three groups of compounds. The first will focused on psychedelics that are \"well defined\" and researched already;; like LSD;; psilocybin;; and MDMA;; he said. The second generation of products will be those that have a large body of anecdotal evidence;; but haven't been researched very much. That includes the Southern Desert Toad psychedelic agent 5-MeO-DMT. The third generation will be focused on unique compounds that Beckley hopes to develop and patent. These synthetic compounds would offer \"clinical and safety advantages over what's already out there;;\" Feilding Mellen said. He said the company aims to have approved psychedelics medications come on the market by 2025;; if not before. ATAI Life Sciences and Compass Pathways;; two of the biggest psychedelics companies;; have offered similar timelines. Take a look at Beckley Psytech's pitch deck below:", "displayName": "Psychedelics", "publishDate": "2020-12-18", "roundSeries": null, "articleTitle": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad", "leadInvestors": null, "deckKindSignal": "raise", "metaExtractedAt": "2026-04-28 07:16:02+00" }, "profile": { "scores": { "yc": 0.3167, "a16z": 0.2816, "docsend": 0.3854, "hoffman": 0.3128, "mcclure": 0.3667, "sequoia": 0.5308, "kawasaki": 0.3167, "nextview": 0.2804, "slidebean": 0.4659, "founder_institute": 0.345 }, "nSlides": 22, "sequence": [ "cover", "disclaimer", "quote_slide", "mission", "executive_summary", "unfair_advantage", "section_divider", "problem_statement", "precedent", "timeline", "why_now", "section_divider", "solution", "team_bio", "team_bio", "unfair_advantage", "section_divider", "competitive_analysis", "unfair_advantage", "solution", "closing_ask", "closing_ask" ], "breakdown": { "yc": { "order": 0.5, "signal": 0, "jaccard": 0.3333 }, "a16z": { "order": 0.5, "signal": 0, "jaccard": 0.2632 }, "docsend": { "order": 0.6364, "signal": 0, "jaccard": 0.3889 }, "hoffman": { "order": 0.4545, "signal": 0, "jaccard": 0.3529 }, "mcclure": { "order": 0.5, "signal": 0.05, "jaccard": 0.3333 }, "sequoia": { "order": 0.4545, "signal": 0.2, "jaccard": 0.3889 }, "kawasaki": { "order": 0.5, "signal": 0, "jaccard": 0.3333 }, "nextview": { "order": 0.4444, "signal": 0, "jaccard": 0.2941 }, "slidebean": { "order": 0.6154, "signal": 0, "jaccard": 0.5625 }, "founder_institute": { "order": 0.4, "signal": 0.05, "jaccard": 0.35 } }, "matchedAt": "2026-04-27 21:51:54+00", "noveltyScore": 0.7692, "primaryScore": 0.5308, "noveltySignals": [ "rare slide types: mission, why_now", "duplicated ≥3×: unfair_advantage", "non-canonical types: disclaimer, precedent, quote_slide, timeline" ], "primaryProfile": "sequoia", "secondaryScore": 0.4659, "secondaryProfile": "slidebean" } }, "slides": [ { "page": 1, "type": "setup", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/pQoCfr57IdPhPl_WIakf3SCAtao9vRJrfLJsgrHORdk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy92Mk0wVTlpaDUxeXhtWGxTc0QxTS9wMDAxLmpwZw", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "sparse", "densityScore": 4, "componentCount": 2, "textChars": 36, "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.653+00", "seconds": 4.147, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/1", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-1", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.176, "w": 0.28, "x": 0.106, "y": 0.058 }, "kind": "image", "text": "Beckley Psytech", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.653+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8374f095-f6e5-40fb-806a-d32e173d219a", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.418, "x": 0.106, "y": 0.358 }, "kind": "title", "text": "Investor Presentation", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.653+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "be64a4b2-4af4-4739-99d7-38f8019ea65c", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/ot158CTI_IUy1s9Z75034BFhR4vGXwxsEb8hVekPFxU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy92Mk0wVTlpaDUxeXhtWGxTc0QxTS9wMDAxLmpwZw", "imagePathAlt": "https://imgproxy.kitesheet.com/OLboQQRYGtMYERWMAQsZt-KLRiw4HLo5sD9KzV5N2sA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy92Mk0wVTlpaDUxeXhtWGxTc0QxTS9wMDAxLnBuZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/SC9MevXBnBpFpcu1pYUsYODg9SH8x-9EkIi0kYmFOM8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy92Mk0wVTlpaDUxeXhtWGxTc0QxTS9wMDAxLnBuZw" }, { "page": 2, "type": "setup", "function": "other", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "balanced", "densityScore": 47, "componentCount": 3, "textChars": 3731, "nDataPoints": 0, "notes": null, "elementsJson": [ "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.761+00", "seconds": 3.924, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/2", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-2", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.3, "w": 0.9, "x": 0.05, "y": 0.5 }, "kind": "disclaimer", "text": "Neither the Company nor any of such its respective directors, officers, employees, affiliates, advisers or agents (the “Associates”) accepts any responsibility, obligation or liability whatsoever for, or makes any representation or warranty, express or implied, as to, and no reliance should be placed on, the fairness, truth, fullness, accuracy, completeness or correctness of, the information in this Presentation or whether any information has been omitted from the Presentation or as to any other information relating to the Company, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss whatsoever arising from any use of this Presentation, its contents or otherwise arising in connection therewith. Except where otherwise indicated in the Presentation, the information provided therein is based on matters as they exist at the date of preparation of the Presentation and not as of any future date and will be subject to updating, revision, verification and amendment without notice and such information may change materially. Neither the Company nor any of its Associates is under an obligation to update, revise or keep current the information contained in this Presentation to which it relates or to provide the recipient of this Presentation with access to any additional information that may arise in connection with it and any opinions expressed in this Presentation are subject to change without notice. Nothing contained in this Presentation is or should be relied upon as a promise or representation as to the future.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.761+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0970c84f-58cb-46ee-8f96-c13503aba432", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.9, "x": 0.05, "y": 0.82 }, "kind": "disclaimer", "text": "The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 and is intended only for those investors who meet the criteria set out in sections 48 and 50 of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.761+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "838b0a73-cf87-4d6d-963e-ef81ca56a421", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "disclaimer", "text": "The following disclaimer applies to this Presentation. For the purposes of this disclaimer, “Presentation” means this document, its contents or any part of it, any oral presentation, any question or answer session and any written or oral material discussed or distributed during the Presentation meeting. The purpose of this Presentation is to provide an overview of Beckley Psytech Ltd (the “Company”). The information in this Presentation is not intended to form the basis of any contract. This Presentation does not constitute an offer or invitation for the sale, issuance or purchase of securities or any businesses or assets described in it, nor does it give or purport to give legal, tax or financial advice. Nothing herein shall be taken as constituting the giving of investment advice or an inducement to enter into investment activity in any jurisdiction and this Presentation is not intended to provide, and must not be taken as, the basis of any decision and should not be considered as an invitation, inducement, solicitation or recommendation to purchase, underwrite, subscribe for or otherwise acquire any securities of the Company. The recipient must make its own independent assessment and such investigations as it deems necessary. Save as set out below, the Presentation has been prepared on the basis of information held by the Company and also from publicly available information. This information, which does not purport to be comprehensive, has not been independently verified by or on behalf of the Company. The Presentation does not constitute an audit or due diligence review and should not be construed as such.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.761+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a6ee9be7-a77e-47ca-8ce9-b79ebfa44676", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "The slide uses a dark background with high-contrast white text to emphasize the emotional impact of the quote.", "function": "inspire_vision", "rawType": "testimonial", "block": null, "metadata": { "slideType": "testimonial", "slideTypeCanon": { "name": "Testimonial", "slug": "testimonial", "status": "active", "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97", "version": 1, "description": null }, "function": "inspire_vision", "functionCanon": { "name": "Inspire vision", "slug": "inspire_vision", "status": "active", "canonId": "019de52d-16d0-7756-83de-376eeac6fa40", "version": 1, "description": null }, "density": "balanced", "densityScore": 37, "componentCount": 3, "textChars": 561, "nDataPoints": 0, "notes": "The slide uses a dark background with high-contrast white text to emphasize the emotional impact of the quote.", "elementsJson": [ "quote_block" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.305+00", "seconds": 4.399, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/3", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-3", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.069, "w": 0.438, "x": 0.108, "y": 0.728 }, "kind": "paragraph", "text": "Patient quote from the Beckley-Imperial psilocybin treatment resistant depression study", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.305+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2d12a125-0407-43b5-a1f9-b24ca152f60c", "parentComponentId": null }, { "bbox": { "h": 0.556, "w": 0.784, "x": 0.108, "y": 0.125 }, "kind": "quote", "text": "The reset switch had been pressed so everything could run properly, thoughts could run more freely, all these networks could work again. It unlocked certain parts which were restricted before.", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": null, "subkind": { "name": "Testimonial", "slug": "testimonial", "status": "active", "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8", "version": 1, "description": null }, "framework": null }, "subkind": "testimonial", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.305+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "73835755-f4a7-432e-ac4c-e182209e605f", "parentComponentId": null }, { "bbox": null, "kind": "quote", "text": "The reset switch had been pressed so everything could run properly, thoughts could run more freely, all these networks could work again. It unlocked certain parts which were restricted before. - Patient quote from the Beckley-Imperial psilocybin treatment resistant depression study", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:39+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8c-e25523b241fd", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 4, "type": "setup", "function": "inspire_vision", "rawType": "mission", "block": null, "metadata": { "slideType": "mission", "slideTypeCanon": { "name": "Mission", "slug": "mission", "status": "active", "canonId": "019de52d-0fce-7496-b34c-18fd6a6e3310", "version": 1, "description": null }, "function": "inspire_vision", "functionCanon": { "name": "Inspire vision", "slug": "inspire_vision", "status": "active", "canonId": "019de52d-16d0-7756-83de-376eeac6fa40", "version": 1, "description": null }, "density": "balanced", "densityScore": 35, "componentCount": 4, "textChars": 337, "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text", "paragraph", "photo" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:49.58+00", "seconds": 5.604, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/4", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-4", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Our mission is to help patients suffering from neuropsychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:39+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8c-72d502ea75c7", "parentComponentId": null }, { "bbox": { "h": 1, "w": 0.45, "x": 0.55, "y": 0 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:49.58+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "13c8b9bc-1814-4c9e-baac-aeed117de45f", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.45, "x": 0.05, "y": 0.25 }, "kind": "paragraph", "text": "Our mission is to help patients suffering from neuropsychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:49.58+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ab69e10f-6c6a-495f-9129-5bb2fcd47108", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.2, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Our Mission", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:49.58+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d47e610e-1d93-465a-80a9-67c4f9b4c92a", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 5, "type": "setup", "title": "The slide uses a honeycomb/hexagonal layout to present four key pillars of the business.", "function": "summarize", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 37, "componentCount": 2, "textChars": 553, "nDataPoints": 1, "notes": "The slide uses a honeycomb/hexagonal layout to present four key pillars of the business.", "elementsJson": [ "headline_text", "numbered_list", "other" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:46.347+00", "seconds": 2.254, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/5", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-5", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.9, "x": 0.05, "y": 0.2 }, "kind": "list", "text": "01: Developing psychedelic compounds as a transformative new class of medicine for neuropsychiatric diseases. 02: Team combines unmatched psychedelic research and drug development expertise and has proven track-record of success in biotech startups. 03: Drug development platform approach to manage risk and maximise commercial value. 04: Company is raising $18m to advance core programs through key development milestones as set out in this presentation.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Numbered list", "slug": "numbered", "status": "active", "canonId": "019de52c-fcc0-7718-a284-a4250c805df2", "version": 1, "description": null }, "framework": null }, "subkind": "numbered", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.347+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bebee16e-d5fc-4205-86bf-9ad47df96ff4", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.94, "x": 0.03, "y": 0.04 }, "kind": "title", "text": "Beckley Psytech: A leading Psychedelic Drug Development Platform positioned for significant growth", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.347+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4b9850f7-2b22-4e24-9048-72ae493600e4", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "5ebb2e79-3ce8-4a39-b6e3-ef9b190f2fb4", "evidence": "Beckley Psytech: A leading Psychedelic Drug Development Platform positioned for significant growth", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 22:31:52.387704+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 6, "type": "evidence", "title": "The slide uses a two-column layout to contrast scientific credibility with commercial exit performance.", "function": "cite_precedent", "rawType": "unfair_advantage", "block": null, "metadata": { "slideType": "unfair_advantage", "slideTypeCanon": { "name": "Unfair advantage", "slug": "unfair_advantage", "status": "active", "canonId": "019de52d-0f56-744f-8bb4-c8a8cca240d6", "version": 1, "description": null }, "function": "cite_precedent", "functionCanon": { "name": "Cite precedent", "slug": "cite_precedent", "status": "active", "canonId": "019de52d-142b-714b-86d4-58aad7b568ec", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 6, "textChars": 582, "nDataPoints": 5, "notes": "The slide uses a two-column layout to contrast scientific credibility with commercial exit performance.", "elementsJson": [ "headline_text", "bullet_list", "other" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:50.268+00", "seconds": 6.128, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/6", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-6", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.15, "x": 0.07, "y": 0.22 }, "kind": "image", "text": "Beckley Foundation Logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a9b26648-96a9-4d6f-85ac-a4b5231505f9", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.57, "y": 0.22 }, "kind": "image", "text": "Beckley Canopy Therapeutics Logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bea051af-2cf5-4ab8-b148-709fa3d02be4", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.4, "x": 0.55, "y": 0.25 }, "kind": "list", "text": "Startup Success; Core leadership team founded biotech company in 2018; Successful Exit; Sold company in 2019 to Canopy Growth Corporation; 3.3x; More than a 3.3x return for investors in 13 months.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "42c2b9ad-e892-4077-baf5-60c09adc1d6d", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.4, "x": 0.05, "y": 0.25 }, "kind": "list", "text": "20+ Years Experience; 50+ Publications; 1st Brain imaging studies on LSD and psilocybin; 1st Psilocybin Treatment Resistant Depression study; 1st LSD micro-dosing clinical study.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b84bf7af-5c55-4f7d-b83f-c83c732b4733", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Return on investment: 3.3x", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:39+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8c-cd0164669b63", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "The Beckley Advantage: An unparalleled track record of pioneering psychedelic science and building successfull biotech startups", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c79af3e-a79d-4024-a1fd-8b2a3649442d", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "e98cdbb0-eb38-4d42-b72f-7afd7f8da9d0", "evidence": "Leveraging academic research history to validate commercial startup potential.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:50.268+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "credibility-transfer" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 7, "type": "setup", "title": "The slide uses a stylized, grainy aesthetic with abstract wing and globe imagery.", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 3, "componentCount": 2, "textChars": 23, "nDataPoints": 0, "notes": "The slide uses a stylized, grainy aesthetic with abstract wing and globe imagery.", "elementsJson": [ "headline_text" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.504+00", "seconds": 4.148, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/7", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-7", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.125, "w": 0.558, "x": 0.104, "y": 0.413 }, "kind": "title", "text": "The Opportunity", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.504+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e452c476-4353-4634-a01a-23ef637f3d2e", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.095, "x": 0.104, "y": 0.293 }, "kind": "title", "text": "Part one", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.504+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca8f1302-a98e-4334-9087-95c2efc994cb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 8, "type": "tension", "function": "frame_problem", "rawType": "problem_statement", "block": null, "metadata": { "slideType": "problem_statement", "slideTypeCanon": { "name": "Problem statement", "slug": "problem_statement", "status": "active", "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4", "version": 1, "description": null }, "function": "frame_problem", "functionCanon": { "name": "Frame problem", "slug": "frame_problem", "status": "active", "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398", "version": 1, "description": null }, "density": "dense", "densityScore": 68, "componentCount": 8, "textChars": 330, "nDataPoints": 3, "notes": null, "elementsJson": [ "action_title", "icon_grid", "big_number" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.171+00", "seconds": 2.754, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/8", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-8", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.05, "w": 0.25, "x": 0.4, "y": 0.65 }, "kind": "metric", "text": "$6 trillion", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "34b31a29-6a32-4b62-a70a-eace21fb6e4b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.25, "x": 0.7, "y": 0.65 }, "kind": "metric", "text": "33% of patients", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "482bf8bc-ee86-4de5-9cd3-7b35949ab810", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.25, "x": 0.1, "y": 0.65 }, "kind": "metric", "text": "1 in 4 people", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8280d823-4bc3-4880-9b00-cd8d125581fa", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "treatment resistance: 33%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:40+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8c-fd5054c487f3", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.25, "x": 0.4, "y": 0.72 }, "kind": "subtitle", "text": "Anticipated cost of treating global mental illness by 2030.", "attrs": null, "canon": { "kind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce", "version": 1, "description": "Header-zone supporting text near the title (= ex body.description with bbox)." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c65995e-fbbf-42a8-b56d-cf06de4c5d1c", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.25, "x": 0.1, "y": 0.72 }, "kind": "subtitle", "text": "Suffering from neurological and psychiatric disorders.", "attrs": null, "canon": { "kind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce", "version": 1, "description": "Header-zone supporting text near the title (= ex body.description with bbox)." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5cc398d3-c665-426b-8ada-846c6e6e4fa8", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.25, "x": 0.7, "y": 0.72 }, "kind": "subtitle", "text": "Resistant to available treatments.", "attrs": null, "canon": { "kind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce", "version": 1, "description": "Header-zone supporting text near the title (= ex body.description with bbox)." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e29057f5-4d7a-4632-a2f2-db8ac43da482", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "The Problem: A global epidemic of psychiatric & neurological disease with huge unmet need for more effective treatments", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.171+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fd6cf2b0-8cf8-4497-a056-1d39182f16d0", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 8, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 8, "name": "Problem", "beatId": "1992a52c-562b-47d0-93a8-64dd2cb68b0a", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Problem", "slug": "sequoia-pitch-problem", "status": "active", "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311", "version": 1, "description": null }, "evidence": "The problem statement is clearly outlined on page 8", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 9, "type": "setup", "function": "argue_timing", "rawType": "why_now", "block": null, "metadata": { "slideType": "why_now", "slideTypeCanon": { "name": "Why now", "slug": "why_now", "status": "active", "canonId": "019de52d-0f2e-718d-b8ad-256dd87582d0", "version": 1, "description": null }, "function": "argue_timing", "functionCanon": { "name": "Argue timing (why now)", "slug": "argue_timing", "status": "active", "canonId": "019de52d-16f8-74de-9ec2-900be07d90dd", "version": 1, "description": null }, "density": "dense", "densityScore": 61, "componentCount": 6, "textChars": 391, "nDataPoints": 4, "notes": null, "elementsJson": [ "action_title", "bullet_list", "other" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.645+00", "seconds": 3.199, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/9", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-9", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.2, "w": 0.4, "x": 0.05, "y": 0.28 }, "kind": "image", "text": "Epidiolex", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "010a873c-6f6b-4aa0-b496-90547e5c6287", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.4, "x": 0.55, "y": 0.28 }, "kind": "image", "text": "Spravato", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8a061a73-499d-4d6d-861e-af9ab35ca527", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.4, "x": 0.05, "y": 0.55 }, "kind": "list", "text": "GW Pharma cannabis-based pharmaceutical for rare pediatric epilepsy. FDA approved. $2bn peak sales forecast.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "88b72697-a61f-4cbb-884c-8aa2d819bdaa", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.4, "x": 0.55, "y": 0.55 }, "kind": "list", "text": "Johnson & Johnson ketamine-derivative pharmaceutical for treatment-resistant depression. FDA approved. $1.35bn peak sales forecast.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ea421beb-3682-40c0-9e1f-d0df45a10a05", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "peak sales forecast: $2bn", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:39+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8c-5e44eb0975a7", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.94, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "The Opportunity: Psychoactive and naturally-derived drugs are proving to be effective pharmaceutical medicines", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d564ab6f-3cc3-4169-97b3-9353b0422488", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "876d825a-e40d-4efb-81b2-68c87b331324", "evidence": "Citing FDA-approved drugs as proof of market viability", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:47.645+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "authority-citation" } ], "arcBeats": [], "loops": [ { "to": 11, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null }, "matchId": "73496664-182b-4790-bfd4-11bd301d81a0", "evidence": "The deck highlights macroeconomic drivers and the current opportunity on pages 9-11", "position": 0, "objective": "Why now is the right time for psychedelic drug development", "confidence": 0.7, "extraction": { "at": "2026-07-16 21:39:52.216559+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "evidence", "title": "The slide uses a hexagonal honeycomb-style timeline layout.", "function": "show_traction", "rawType": "timeline", "block": null, "metadata": { "slideType": "timeline", "slideTypeCanon": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-0851-75eb-b758-ea2965e7739a", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "balanced", "densityScore": 38, "componentCount": 2, "textChars": 515, "nDataPoints": 5, "notes": "The slide uses a hexagonal honeycomb-style timeline layout.", "elementsJson": [ "timeline_visual", "headline_text" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.183+00", "seconds": 2.732, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/10", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-10", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.55, "w": 0.94, "x": 0.03, "y": 0.29 }, "kind": "framework", "text": "2005: Alcohol Addiction, Ayahuasca, Significant reduction in alcohol use. 2014: Tobacco Addiction, Psilocybin, 80% of patients smoke free. 2015: Depression, Ayahuasca, 82% reduction in depression scales. 2016: Treatment-Resistant Depression, Psilocybin, 63% remission rates. 2016: Existential Distress, Psilocybin, 80% response rate. Ongoing: Cluster Headache & Migraine, Psilocybin.", "attrs": null, "canon": { "kind": { "name": "Framework", "slug": "framework", "status": "active", "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa", "version": 1, "description": "Named conceptual framework instance." }, "tool": null, "subkind": { "name": "Framework instance", "slug": "instance", "status": "active", "canonId": "019de52d-05a2-72af-be0b-7edc60708a03", "version": 1, "description": null }, "framework": null }, "subkind": "instance", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.183+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7969194d-90b2-4dab-bb44-ea578adf4871", "parentComponentId": null }, { "bbox": { "h": 0.21, "w": 0.94, "x": 0.03, "y": 0.04 }, "kind": "title", "text": "Psychedelics: A new class of neuropsychiatric treatment with blockbuster potential, but further pharmaceutical development is needed", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.183+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "95948727-e4d1-4e3b-9c00-cb22f09f1cbe", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "f2177757-55fc-47ff-8105-62a6b4a560e9", "evidence": "Chronological sequence of clinical research events.", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 16:20:47.183+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 10, "frameworkName": "timeline" } ], "arcBeats": [], "loops": [ { "to": 11, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null }, "matchId": "73496664-182b-4790-bfd4-11bd301d81a0", "evidence": "The deck highlights macroeconomic drivers and the current opportunity on pages 9-11", "position": 0, "objective": "Why now is the right time for psychedelic drug development", "confidence": 0.7, "extraction": { "at": "2026-07-16 21:39:52.216559+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 11, "type": "setup", "title": "Uses authority bias by citing major news outlets to establish market timing.", "function": "argue_timing", "rawType": "why_now", "block": null, "metadata": { "slideType": "why_now", "slideTypeCanon": { "name": "Why now", "slug": "why_now", "status": "active", "canonId": "019de52d-0f2e-718d-b8ad-256dd87582d0", "version": 1, "description": null }, "function": "argue_timing", "functionCanon": { "name": "Argue timing (why now)", "slug": "argue_timing", "status": "active", "canonId": "019de52d-16f8-74de-9ec2-900be07d90dd", "version": 1, "description": null }, "density": "sparse", "densityScore": 24, "componentCount": 3, "textChars": 272, "nDataPoints": 0, "notes": "Uses authority bias by citing major news outlets to establish market timing.", "elementsJson": [ "headline_text", "logo_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:46.945+00", "seconds": 2.488, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/11", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-11", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.6, "w": 0.9, "x": 0.05, "y": 0.25 }, "kind": "image", "text": "Bloomberg, Forbes, Financial Times, Sifted, Wired, Daily Mail", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.945+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "49cd7389-010f-4eea-852a-4580eefd8ad3", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.9, "x": 0.05, "y": 0.25 }, "kind": "list", "text": "Six media headlines with dates demonstrating industry momentum.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.945+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "27e0c095-a81e-4d21-8a2f-83b2bbce6b2f", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Why Now? Powerful macroeconomic drivers offer a window of opportunity and Beckley Psytech is uniquely positioned as a leader in this emerging market", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.945+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b731a5a7-52a9-4521-91e3-30c0e2c6f81b", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "5478cb64-13e8-4a18-9989-a09fd0850b9a", "evidence": "Citing reputable news sources to validate market timing.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:46.945+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "authority-bias" } ], "arcBeats": [], "loops": [ { "to": 11, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null }, "matchId": "73496664-182b-4790-bfd4-11bd301d81a0", "evidence": "The deck highlights macroeconomic drivers and the current opportunity on pages 9-11", "position": 0, "objective": "Why now is the right time for psychedelic drug development", "confidence": 0.7, "extraction": { "at": "2026-07-16 21:39:52.216559+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 12, "type": "setup", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 3, "componentCount": 2, "textChars": 23, "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:46.959+00", "seconds": 2.306, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/12", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-12", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.117, "w": 0.555, "x": 0.104, "y": 0.408 }, "kind": "title", "text": "Strategy & Team", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7044f7ad-e970-4bb9-ab29-d04931e67b1e", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.095, "x": 0.104, "y": 0.292 }, "kind": "title", "text": "Part two", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:46.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "61a10e74-2f1c-4f4b-a16b-878b19ca5757", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 13, "type": "resolution", "title": "The slide uses a tiered structure to categorize R&D efforts by innovation level.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "balanced", "densityScore": 45, "componentCount": 4, "textChars": 539, "nDataPoints": 0, "notes": "The slide uses a tiered structure to categorize R&D efforts by innovation level.", "elementsJson": [ "action_title", "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.409+00", "seconds": 2.525, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/13", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-13", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.88, "x": 0.06, "y": 0.32 }, "kind": "list", "text": "1st Generation Program: Progressing innovative formulations and novel applications of well-characterized psychedelic agents.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.409+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1c8ca36b-7e0f-457a-999d-bc58ed95a3db", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.88, "x": 0.06, "y": 0.48 }, "kind": "list", "text": "2nd Generation Program: Develop known but under-researched psychedelic agents offering stronger IP, clinical, and patient access advantages.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.409+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a9fa3f4b-73db-4c98-b543-fb0de064b290", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.88, "x": 0.06, "y": 0.66 }, "kind": "list", "text": "3rd Generation Program: Design New Chemical Entities (NCEs) that improve upon existing psychedelics by providing better patient and health economic outcomes.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.409+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dd89360f-3509-4ab3-81c4-0926e9735a8f", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.94, "x": 0.03, "y": 0.04 }, "kind": "title", "text": "Drug Development Platform: Building a portfolio of psychedelic assets to manage risk and maximise commercial potential", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.409+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cb3b605b-1249-4c46-b8e3-55ad7a840ff4", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "d7bc8ea7-3e20-4002-ad0a-1570c200a276", "evidence": "The slide categorizes development programs into 1st, 2nd, and 3rd generations, representing increasing levels of innovation and complexity.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 16:20:47.409+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 13, "frameworkName": "maturity-model" } ], "arcBeats": [ { "to": 13, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 13, "name": "Solution", "beatId": "5446c3f5-6fb8-46c6-8fbf-e9043d2e5999", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The solution is described on page 13", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 14, "type": "setup", "title": "The slide uses a grid layout to display 10 team members.", "function": "other", "rawType": "team_bio", "block": null, "metadata": { "slideType": "team_bio", "slideTypeCanon": { "name": "Team bio", "slug": "team_bio", "status": "active", "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "balanced", "densityScore": 30, "componentCount": 4, "textChars": 241, "nDataPoints": 0, "notes": "The slide uses a grid layout to display 10 team members.", "elementsJson": [ "headline_text", "headshot", "logo_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.102+00", "seconds": 2.212, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/14", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-14", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Visit www.beckleypsytech.com for detailed bios", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:42+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8e-69418bdbea7b", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.9, "x": 0.05, "y": 0.2 }, "kind": "image", "text": "10 headshots of team members", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0e607e3d-eb63-4ca8-85b4-1831404d8a96", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.05, "y": 0.92 }, "kind": "paragraph", "text": "Visit www.beckleypsytech.com for detailed bios", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4f9bbe7b-46fb-4480-a5c9-f3947256a07a", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Leadership Team: World-leading psychedelic researchers, drug development experts and business shapers with proven success", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "21eb5bd5-d2da-4e3d-a3a2-674ed96c03e9", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "bf75e02d-622a-4d14-a94e-87710c5f081d", "evidence": "Leadership Team: World-leading psychedelic researchers, drug development experts and business shapers with proven success", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:31:40.827081+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Authority Bias", "slug": "authority-bias", "status": "active", "bestFor": null, "canonId": "019dd956-c38d-70b9-a284-b2b479763356", "version": 1, "bodyDocId": null, "description": "Expert opinions are weighted more heavily - cite credible sources", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Architect", "Storyteller" ], "matchId": "558008c9-a2e1-45f0-8a76-f704e0204def", "evidence": "World-leading psychedelic researchers, drug development experts and business shapers with proven success", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:40.87067+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 15, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 14, "name": "Team", "beatId": "ac05d62d-4136-4eff-9e6c-66111ab0e59f", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Team", "slug": "sequoia-pitch-team", "status": "active", "canonId": "019dd9b8-23c9-746f-aaf9-2f5d83892cf3", "version": 1, "description": null }, "evidence": "The leadership team and scientific advisors are introduced on pages 14-15", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 15, "type": "setup", "title": "The slide uses a hierarchical structure to establish credibility through institutional affiliations.", "function": "other", "rawType": "team_bio", "block": null, "metadata": { "slideType": "team_bio", "slideTypeCanon": { "name": "Team bio", "slug": "team_bio", "status": "active", "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "balanced", "densityScore": 25, "componentCount": 3, "textChars": 299, "nDataPoints": 0, "notes": "The slide uses a hierarchical structure to establish credibility through institutional affiliations.", "elementsJson": [ "headline_text", "action_title", "org_chart", "logo_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.744+00", "seconds": 2.696, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/15", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-15", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.6, "w": 0.9, "x": 0.05, "y": 0.25 }, "kind": "diagram", "text": "Hierarchical structure of Scientific Advisory Board", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Org chart", "slug": "org-chart", "status": "active", "canonId": "019de52d-04b3-709a-9328-bbcb1643bbc1", "version": 1, "description": null }, "framework": null }, "subkind": "org-chart", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.744+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5742548-c413-4b74-9973-458fdb891b5f", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.9, "x": 0.05, "y": 0.65 }, "kind": "image", "text": "Institutional logos: Oxford, King's College, Johns Hopkins, Imperial College, Manchester University, Sinto Pharma", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.744+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a7955727-f576-42e9-b969-41713ec97992", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Scientific Advisors: Providing world-leading expertise across the development pathway and scientific objectivity to our decision making", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.744+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4f965219-1872-4473-8df8-b74ebae5afde", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "62584930-54a6-48a4-9057-21f6b7ee75ea", "evidence": "Providing world-leading expertise across the development pathway and scientific objectivity to our decision making", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 22:31:40.956008+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Credibility Transfer", "slug": "credibility-transfer", "status": "active", "bestFor": null, "canonId": "019dd956-bd34-759a-8e3b-2f14b571a2a1", "version": 1, "bodyDocId": null, "description": "Borrowing authority from trusted sources or vivid details", "familyLabel": null, "categoryName": "Slide", "categorySlug": "slide" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "3acf9e5e-44f3-4574-b20d-9bb7214b9bf9", "evidence": "Institutional logos: Oxford, King's College, Johns Hopkins, Imperial College, Manchester University, Sinto Pharma", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:40.999247+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 15, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 14, "name": "Team", "beatId": "ac05d62d-4136-4eff-9e6c-66111ab0e59f", "matchId": "36b20947-b732-493b-ab23-13cdf37c0a29", "beatType": { "name": "Team", "slug": "sequoia-pitch-team", "status": "active", "canonId": "019dd9b8-23c9-746f-aaf9-2f5d83892cf3", "version": 1, "description": null }, "evidence": "The leadership team and scientific advisors are introduced on pages 14-15", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 16, "type": "appendix", "title": "The slide highlights a symbiotic relationship: the company gains access to IP/data/deal flow, while the foundation receives a share of future revenues.", "function": "establish_context", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "dense", "densityScore": 64, "componentCount": 6, "textChars": 632, "nDataPoints": 0, "notes": "The slide highlights a symbiotic relationship: the company gains access to IP/data/deal flow, while the foundation receives a share of future revenues.", "elementsJson": [ "headline_text", "icon_grid", "logo_grid", "paragraph" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.429+00", "seconds": 3.348, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/16", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-16", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Beckley Psytech is committed to improving the lives of patients in need and will donate a share of future revenues to fund the non-profit work of the Beckley Foundation.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:41+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8d-83638296b2df", "parentComponentId": null }, { "bbox": { "h": 0.79, "w": 0.33, "x": 0.638, "y": 0.3 }, "kind": "image", "text": "Beckley Foundation and partner university logos", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.429+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "48c184b0-3cc7-476b-a2ab-0ea94854c3fb", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.55, "x": 0.05, "y": 0.38 }, "kind": "list", "text": "Big Data, Deal Flow, Pipeline of IP", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.429+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d1da3bd0-1e52-4951-bcc1-1d5fd6e02fd5", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.55, "x": 0.05, "y": 0.71 }, "kind": "paragraph", "text": "Beckley Psytech is committed to improving the lives of patients in need and will donate a share of future revenues to fund the non-profit work of the Beckley Foundation.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.429+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4eb28769-cdf5-465a-a257-986877fc365f", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.3, "x": 0.05, "y": 0.3 }, "kind": "paragraph", "text": "Beckley Foundation can provide:", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.429+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fccb98de-1ada-4df8-b47c-3f20afb96a21", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Global Research Network: Close strategic partnership with the Beckley Foundation opens up opportunities from a network of ongoing and future research collaborations around the world", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.429+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c01a2e4d-8bca-40f8-b2b8-6a840ee861a0", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Network Effects Flywheel", "slug": "network-effects-flywheel", "status": "active", "bestFor": null, "canonId": "79fa8d3e-ef02-4ee8-ad12-f8e00a25cca1", "version": 1, "bodyDocId": null, "description": null, "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "c114878c-8de2-49a5-94cd-c8dc21b0049a", "evidence": "Global Research Network: Close strategic partnership with the Beckley Foundation opens up opportunities from a network of ongoing and future research collaborations around the world", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:41.087721+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 16, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 17, "type": "setup", "title": "The slide uses a stylized, abstract background graphic.", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 5, "componentCount": 2, "textChars": 41, "nDataPoints": 0, "notes": "The slide uses a stylized, abstract background graphic.", "elementsJson": [ "headline_text" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:47.16+00", "seconds": 1.978, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/17", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-17", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.233, "w": 0.608, "x": 0.104, "y": 0.388 }, "kind": "title", "text": "Research & Competitive Position", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.16+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "54b854a3-c77e-4b6f-baed-ef78562b68a5", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.114, "x": 0.104, "y": 0.263 }, "kind": "title", "text": "Part three", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:47.16+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bd230858-543a-4966-8d07-8afac93c280b", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 18, "type": "setup", "title": "The slide uses a tiered layout to represent a progression of innovation or maturity.", "function": "compare_peers", "rawType": "competitive_analysis", "block": null, "metadata": { "slideType": "competitive_analysis", "slideTypeCanon": { "name": "Competitive analysis", "slug": "competitive_analysis", "status": "active", "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31", "version": 1, "description": null }, "function": "compare_peers", "functionCanon": { "name": "Compare peers", "slug": "compare_peers", "status": "active", "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630", "version": 1, "description": null }, "density": "dense", "densityScore": 59, "componentCount": 5, "textChars": 783, "nDataPoints": 0, "notes": "The slide uses a tiered layout to represent a progression of innovation or maturity.", "elementsJson": [ "action_title", "bullet_list" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.501+00", "seconds": 3.307, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/18", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-18", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.12, "w": 0.94, "x": 0.03, "y": 0.58 }, "kind": "list", "text": "3rd Generation (NCEs): Composition of matter IP. Potential clinical and safety advantages over existing psychedelic compounds.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3a3f84b1-5c00-4680-ad58-65d1509ba5f5", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.94, "x": 0.03, "y": 0.26 }, "kind": "list", "text": "1st Generation (Confidential): Differentiated application, market segment, and treatment model. Additional data and market exclusivity protections.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "83e2c3d6-b853-42f6-a31c-ebcfac70f733", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.94, "x": 0.03, "y": 0.41 }, "kind": "list", "text": "2nd Generation (5-MeO-DMT): Early Mover in 5-MeO-DMT. Strong potential for innovation, IP, and market exclusivity protection. Significant market access and resource efficiencies over longer-acting psychedelics.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c7c13a0-9618-4cc1-be4e-04eaec886cd2", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.94, "x": 0.03, "y": 0.73 }, "kind": "list", "text": "Beckley Deep Labs: Horizon scanning to guide advanced research and differentiated development programs. Accelerated expansion of the Beckley Psytech platform with pioneering partnerships.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b2508f6e-c83e-4ba0-841e-3a2af99a961a", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.85, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Competitive Positioning: Each program offers clear market differentiation with clinical and commercial advantages", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "403d856d-7a3c-4dbe-b125-4b5d41fb1d93", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Market Segmentation Pyramid", "slug": "market-segmentation-pyramid", "status": "active", "bestFor": null, "canonId": "1c9f3543-c96f-4a5b-b4a4-9b2a412c0aaf", "version": 1, "bodyDocId": null, "description": null, "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "0ed014b1-4ec1-429d-89a4-675f88fc79d4", "evidence": "2nd Generation (5-MeO-DMT): Early Mover in 5-MeO-DMT. Strong potential for innovation, IP, and market exclusivity protection", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.5, "extraction": { "at": "2026-07-16 22:31:41.219553+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 18, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "c409dda2-d11f-4131-9f5a-1357de387174", "evidence": "The slide organizes programs into generations (1st, 2nd, 3rd) representing a progression of development.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 16:20:48.501+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 18, "frameworkName": "maturity-model" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 19, "type": "resolution", "title": "The slide uses a honeycomb/hexagonal layout to present four key pillars of the drug's value proposition.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 57, "componentCount": 5, "textChars": 701, "nDataPoints": 0, "notes": "The slide uses a honeycomb/hexagonal layout to present four key pillars of the drug's value proposition.", "elementsJson": [ "headline_text", "action_title", "icon_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.228+00", "seconds": 2.92, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/19", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-19", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.35, "w": 0.25, "x": 0.26, "y": 0.45 }, "kind": "diagram", "text": "Formulation Design: Intellectual Property. Customized for preferred PK profile. Patient friendly.", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": "other", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.228+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c0c4be7-0258-434c-a6dc-572c883bdb9c", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.25, "x": 0.48, "y": 0.18 }, "kind": "diagram", "text": "Regulatory & IP Opportunities: Data exclusivity. De-risked for unexpected safety signals due to extensive human use. Early mover advantage presents multiple IP opportunities.", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": "other", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.228+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "590b280a-5c3c-4ef7-af26-60dbdc7b0842", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.25, "x": 0.72, "y": 0.5 }, "kind": "diagram", "text": "Research Attractiveness: Top KOLs attached to study. High level of anecdotal & observational reports of therapeutic efficacy in depression, addiction, and anxiety. Clinical research needed.", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": "other", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.228+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5fedbf3f-5b0f-4328-a761-a7ce008c9c25", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.25, "x": 0.02, "y": 0.23 }, "kind": "diagram", "text": "Clinical Differentiation: Short-acting & potent. Reliable induction of peak experience. Unique receptor binding profile", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": "other", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.228+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5936d4a-185e-4494-8f0f-f089d2dbb35e", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "In Depth - 5-MeO-DMT: \"2nd Generation\" psychedelic medicine with significant patient access, commercial, and IP advantages", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.228+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2b44c984-6784-4382-9064-2d8bf64ff3dc", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 20, "type": "appendix", "title": "The diagram is a 4-circle Venn diagram representing the intersection of Foundation, Science, Technology, and Partnerships.", "function": "present_framework", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "balanced", "densityScore": 38, "componentCount": 3, "textChars": 571, "nDataPoints": 0, "notes": "The diagram is a 4-circle Venn diagram representing the intersection of Foundation, Science, Technology, and Partnerships.", "elementsJson": [ "headline_text", "action_title", "venn_diagram", "icon_grid" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.959+00", "seconds": 3.312, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/20", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-20", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.55, "w": 0.45, "x": 0.05, "y": 0.3 }, "kind": "diagram", "text": "Venn diagram showing Beckley Deep Labs at the center of Foundation, Advanced Science, Advanced Technology, and Pioneering Partnerships.", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Venn diagram", "slug": "venn", "status": "active", "canonId": "019de52d-0463-710d-b529-cce18d828d2f", "version": 1, "description": null }, "framework": null }, "subkind": "venn", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8a603eb7-df76-49b0-922e-6485772ad0c0", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.45, "x": 0.52, "y": 0.35 }, "kind": "list", "text": "AI / Machine Learning to accelerate and improve clinical development outcomes. Novel psychedelic therapeutic applications in preclinical disease models. Signal finding and mechanistic research to inform NCE development program. Advanced technologies for enhanced therapeutic outcomes.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1eb0d505-ce06-42b2-a73c-7db83cf3a664", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.94, "x": 0.03, "y": 0.04 }, "kind": "title", "text": "Beckley Deep Labs: Advanced research division driving innovation, finding next generation programs, and staying at the forefront of psychedelic research", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2595389e-a141-4751-bbb9-0ca2155c1de3", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "61835825-275c-4c41-a5a1-77387764b098", "evidence": "Four overlapping circles illustrating the intersection of organizational pillars.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 16:20:48.959+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 20, "frameworkName": "venn-diagram" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 21, "type": "setup", "function": "state_next_steps", "rawType": "closing_ask", "block": null, "metadata": { "slideType": "closing_ask", "slideTypeCanon": { "name": "Closing ask", "slug": "closing_ask", "status": "active", "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c", "version": 1, "description": null }, "function": "state_next_steps", "functionCanon": { "name": "State next steps", "slug": "state_next_steps", "status": "active", "canonId": "019de52d-14ca-70ac-b534-971f458cdf29", "version": 1, "description": null }, "density": "dense", "densityScore": 70, "componentCount": 6, "textChars": 690, "nDataPoints": 1, "notes": null, "elementsJson": [ "headline_text", "bullet_list", "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:48.206+00", "seconds": 2.527, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/21", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-21", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Fundraising: Autumn 2020, we are raising $18m in order to:", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:44+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8f-3a1931e0c94c", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.55, "x": 0.42, "y": 0.45 }, "kind": "list", "text": "Fundraising: Autumn 2020, we are raising $18m in order to: 1st Generation: Conduct Proof-of-Concept trial. 2nd Generation: Complete 'First in Man' Phase 1 trial. 3rd Generation: Advance internal NCE development. Launch advanced research programs.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.206+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0153981d-35cd-47df-9704-af19016b1f22", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.55, "x": 0.42, "y": 0.1 }, "kind": "list", "text": "Beckley Psytech is a leader in the emerging psychedelic medicines market and positioned for significant growth. Team combines world-leading psychedelic research and drug development expertise. Drug development platform approach to manage risk.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.206+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f86bd84b-c6fe-4f01-8542-d1a3e1665477", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Fundraising target: $18m", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-27 15:50:44+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd952-d526-758a-9c8f-3f9b042a161a", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.05, "y": 0.8 }, "kind": "paragraph", "text": "Thank you for your interest. For more information email: info@beckleypsytech.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.206+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bb7b39b9-58cf-4eeb-88d8-0dd748095668", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.35, "x": 0.05, "y": 0.1 }, "kind": "title", "text": "Right Projects, Right Team, Right Time.", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:48.206+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7a2f97a5-370e-4245-971d-0cb061bbb1ac", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Call to action", "slug": "call-to-action", "status": "active", "bestFor": null, "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c", "version": 1, "bodyDocId": null, "description": "Explicit prescription of what the audience should do next.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "8a7acdae-5cc8-4976-9eb6-5f9129d86c1b", "evidence": "Right Projects, Right Team, Right Time.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 22:31:41.394345+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 21, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 22, "type": "setup", "function": "state_next_steps", "rawType": "closing_ask", "block": null, "metadata": { "slideType": "closing_ask", "slideTypeCanon": { "name": "Closing ask", "slug": "closing_ask", "status": "active", "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c", "version": 1, "description": null }, "function": "state_next_steps", "functionCanon": { "name": "State next steps", "slug": "state_next_steps", "status": "active", "canonId": "019de52d-14ca-70ac-b534-971f458cdf29", "version": 1, "description": null }, "density": "balanced", "densityScore": 27, "componentCount": 3, "textChars": 321, "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 16:20:49.041+00", "seconds": 2.625, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/22", "deck": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7", "deckAnchor": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-22", "deckJson": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json" }, "components": [ { "bbox": { "h": 0.05, "w": 0.56, "x": 0.105, "y": 0.883 }, "kind": "disclaimer", "text": "This presentation is strictly confidential and recipients must not disclose any written or verbal information provided to them in this presentation or thereafter to any third party, without the prior written consent of Beckley Psytech Ltd.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:49.041+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "777af774-aede-408e-8863-a1e8ca0764ed", "parentComponentId": null }, { "bbox": { "h": 0.175, "w": 0.178, "x": 0.105, "y": 0.058 }, "kind": "image", "text": "Beckley Psytech", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:49.041+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ce6cbcb4-0737-434e-8172-5af81258507b", "parentComponentId": null }, { "bbox": { "h": 0.364, "w": 0.79, "x": 0.105, "y": 0.318 }, "kind": "title", "text": "Thank you for your interest in becoming a Beckley Psytech investor.", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 16:20:49.041+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dfd25f9f-12d7-41c2-8fe5-ce2b50fba547", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Storytelling: the closing ask", "slug": "closing-ask", "status": "active", "bestFor": null, "canonId": "019df269-24e0-70ab-8dd9-983832c1c665", "version": 1, "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d", "description": "The single most important slide in the deck — after the cover. The final", "familyLabel": "narrative-block", "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "agent": "storyteller", "layer": "slide", "agents": [ "storyteller" ], "matchId": "c5ec1d25-7dc2-4396-aa26-99e8f0ceccc0", "evidence": "Thank you for your interest in becoming a Beckley Psytech investor.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 22:31:41.480918+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 22, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 8, "to": 8, "label": "Problem", "description": "The problem statement is clearly outlined on page 8" }, { "from": 13, "to": 13, "label": "Solution", "description": "The solution is described on page 13" }, { "from": 14, "to": 15, "label": "Team", "description": "The leadership team and scientific advisors are introduced on pages 14-15" } ], "loops": [ { "from": 9, "to": 11, "label": "Why Now", "description": "Why now is the right time for psychedelic drug development" } ] }